Resmed Inc. buy Needham & Company LLC
Start price
26.04.24
/
50%
€188.65
Target price
26.04.25
€220.14
Performance (%)
11.64%
End price
27.04.25
€210.60
Summary
This prediction ended on 27.04.25 with a price of €210.60. The BUY prediction by Needham___Company_LL finished with a performance of 11.64%. A total of €1.93 was paid as dividends for this prediction. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 0.867% | 0.867% | -19.463% |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% |
Comments by Needham___Company_LL for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $224.00 to $236.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten